日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

MTBVAC在婴儿中的安全性、反应原性和免疫原性:一项在结核病流行地区开展的2a期随机、双盲、剂量确定性试验

Michele Tameris,Virginie Rozot,Claire Imbratta,Hennie Geldenhuys,Simon C Mendelsohn,Angelique Kany Kany Luabeya,Justin Shenje,Nicolette Tredoux,Michelle Fisher,Humphrey Mulenga,Nicole Bilek,Carly Young,Ashley Veldsman,Natasja Botes,Jelle Thole,Bernard Fritzell,Rajat Mukherjee,Ingrid Murillo Jelsbak,Esteban Rodriguez,Eugenia Puentes,Juana Doce,Dessislava Marinova,Jesús Gonzalo-Asensio,Nacho Aguilo,Carlos Martin,Thomas J Scriba,Mark Hatherill  ; MTBVAC study team